• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Opththonix hires financial officer

Article

San Diego—Thomas A. George has joined Ophthonix Inc. as its chief financial officer. George, a CPA with more than 27 years of financial management experience, will oversee all financial controls, organization, and relationships.

San Diego-Thomas A. George has joined Ophthonix Inc. as its chief financial officer. George, a CPA with more than 27 years of financial management experience, will oversee all financial controls, organization, and relationships.

He most recently was chief financial officer of Oakley Inc., a consumer products company providing premium sunglasses, prescription eyewear frames and lenses, and more.

Ophthonix is developing a "high definition" vision correction technology it says will provide superior optical clarity and crispness.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.